{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:36:02Z","timestamp":1780536962415,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,23]]},"DOI":"10.7759\/cureus.105734","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:38:45Z","timestamp":1774327125000},"source":"Crossref","is-referenced-by-count":1,"title":["Testosterone Replacement Therapy as a Potential Strategy to Preserve Lean Mass in Men With Persistently Low Serum Testosterone Receiving GLP-1 Receptor Agonists: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Luis  M","family":"Canal de Velasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Emiliano","family":"Gonz\u00e1lez Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Kraus Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Morales Arteaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda  J","family":"Olivares Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenia N","family":"Alvarez Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frida M","family":"Morales Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding JP","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, et al.. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021, 384:989-1002. 10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff AM","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022, 387:205-16. 10.1056\/NEJMoa2206038","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2010.00298.x","article-title":"A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity","volume":"68","author":"Weinheimer EM","year":"2010","unstructured":"Weinheimer EM, Sands LP, Campbell WW. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev. 2010, 68:375-88. 10.1111\/j.1753-4887.2010.00298.x","journal-title":"Nutr Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-230227","article-title":"Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial","volume":"27","author":"Pasiakos SM","year":"2013","unstructured":"Pasiakos SM, Cao JJ, Margolis LM, et al.. Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB J. 2013, 27:3837-47. 10.1096\/fj.13-230227","journal-title":"FASEB J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino D","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, et al.. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021, 325:1414-25. 10.1001\/jama.2021.3224","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000934","article-title":"Effect of GLP-1 receptor agonists on body composition","volume":"32","author":"Bhandarkar A","year":"2025","unstructured":"Bhandarkar A, Bhat S, Kapoor N. Effect of GLP-1 receptor agonists on body composition. Curr Opin Endocrinol Diabetes Obes. 2025, 32:279-85. 10.1097\/MED.0000000000000934","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft AJ","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, et al.. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019, 48:16-31. 10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis JA","year":"2018","unstructured":"Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018, 14:513-37. 10.1038\/s41574-018-0062-9","journal-title":"Nat Rev Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.103530","article-title":"Testosterone replacement therapy in athletes: implications for injury recovery and musculoskeletal performance","volume":"18","author":"Canal de Velasco LM","year":"2026","unstructured":"Canal de Velasco LM, Gonz\u00e1lez Flores JE, Azcona Cervera A, Morales Arteaga JL, Olivares Casas MJ. Testosterone replacement therapy in athletes: implications for injury recovery and musculoskeletal performance. Cureus. 2026, 18:10.7759\/cureus.103530","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00075197-200405000-00006","article-title":"Testosterone action on skeletal muscle","volume":"7","author":"Herbst KL","year":"2004","unstructured":"Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004, 7:271-7. 10.1097\/00075197-200405000-00006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0883-3","article-title":"Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions","volume":"69","author":"Dubois V","year":"2012","unstructured":"Dubois V, Laurent M, Boonen S, Vanderschueren D, Claessens F. Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions. Cell Mol Life Sci. 2012, 69:1651-67. 10.1007\/s00018-011-0883-3","journal-title":"Cell Mol Life Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-12-0455","article-title":"Testosterone: a metabolic hormone in health and disease","volume":"217","author":"Kelly DM","year":"2013","unstructured":"Kelly DM, Jones TH. Testosterone: a metabolic hormone in health and disease. J Endocrinol. 2013, 217:R25-45. 10.1530\/JOE-12-0455","journal-title":"J Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein JS","year":"2013","unstructured":"Finkelstein JS, Lee H, Burnett-Bowie SA, et al.. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013, 369:1011-22. 10.1056\/NEJMoa1206168","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder PJ","year":"2016","unstructured":"Snyder PJ, Bhasin S, Cunningham GR, et al.. Effects of testosterone treatment in older men. N Engl J Med. 2016, 374:611-24. 10.1056\/NEJMoa1506119","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00362.2001","article-title":"Testosterone administration to older men improves muscle function: molecular and physiological mechanisms","volume":"282","author":"Ferrando AA","year":"2002","unstructured":"Ferrando AA, Sheffield-Moore M, Yeckel CW, et al.. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab. 2002, 282:E601-7. 10.1152\/ajpendo.00362.2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0480-2","article-title":"Testosterone supplementation and body composition: results from a meta-analysis of observational studies","volume":"39","author":"Corona G","year":"2016","unstructured":"Corona G, Giagulli VA, Maseroli E, et al.. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016, 39:967-81. 10.1007\/s40618-016-0480-2","journal-title":"J Endocrinol Invest"},{"key":"ref17","unstructured":"Levels of evidence \u2014 Centre for Evidence-Based Medicine (CEBM), University of Oxford. (2020). Accessed. March 20, 2026: http:\/\/20202020."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0890","article-title":"Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study","volume":"168","author":"Camacho EM","year":"2013","unstructured":"Camacho EM, Huhtaniemi IT, O'Neill TW, et al.. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013, 168:445-55. 10.1530\/EJE-12-0890","journal-title":"Eur J Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin S","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR, et al.. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018, 103:1715-44. 10.1210\/jc.2018-00229","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031069","article-title":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men","volume":"89","author":"Malkin CJ","year":"2004","unstructured":"Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004, 89:3313-8. 10.1210\/jc.2003-031069","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt154","article-title":"Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point","volume":"69","author":"Bachman E","year":"2014","unstructured":"Bachman E, Travison TG, Basaria S, et al.. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin\/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014, 69:725-35. 10.1093\/gerona\/glt154","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12319","article-title":"Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study","volume":"68","author":"Traish AM","year":"2014","unstructured":"Traish AM, Haider A, Doros G, Saad F. Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract. 2014, 68:314-29. 10.1111\/ijcp.12319","journal-title":"Int J Clin Pract"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20407","article-title":"Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss","volume":"21","author":"Saad F","year":"2013","unstructured":"Saad F, Haider A, Doros G, Traish A. Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss. Obesity (Silver Spring). 2013, 21:1975-81. 10.1002\/oby.20407","journal-title":"Obesity (Silver Spring)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06779","article-title":"Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency","volume":"189","author":"Corrales JJ","year":"2006","unstructured":"Corrales JJ, Almeida M, Burgo R, Mories MT, Miralles JM, Orfao A. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. J Endocrinol. 2006, 189:595-604. 10.1677\/joe.1.06779","journal-title":"J Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.47191\/ijmscrs\/v5-i09-14","article-title":"Clinical benefits of testosterone replacement therapy in men: evidence from a narrative review","volume":"5","author":"Aguirre Quintero MF","year":"2025","unstructured":"Aguirre Quintero MF, Gaspar Verduzco MC, Concha Sampedro YG, et al.. Clinical benefits of testosterone replacement therapy in men: evidence from a narrative review. Int J Med Sci Clin Res Stud. 2025, 5:1577-81. 10.47191\/ijmscrs\/v5-i09-14","journal-title":"Int J Med Sci Clin Res Stud"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2018.1482487","article-title":"The relationship between circulating testosterone and inflammatory cytokines in men","volume":"22","author":"Mohamad NV","year":"2019","unstructured":"Mohamad NV, Wong SK, Wan Hasan WN, Jolly JJ, Nur-Farhana MF, Ima-Nirwana S, Chin KY. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2019, 22:129-40. 10.1080\/13685538.2018.1482487","journal-title":"Aging Male"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2014.03.051","article-title":"Elevated mitochondrial biogenesis in skeletal muscle is associated with testosterone-induced body weight loss in male mice","volume":"588","author":"Usui T","year":"2014","unstructured":"Usui T, Kajita K, Kajita T, et al.. Elevated mitochondrial biogenesis in skeletal muscle is associated with testosterone-induced body weight loss in male mice. FEBS Lett. 2014, 588:1935-41. 10.1016\/j.febslet.2014.03.051","journal-title":"FEBS Lett"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1017\/S0029665115000129","article-title":"Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia","volume":"74","author":"Heymsfield SB","year":"2015","unstructured":"Heymsfield SB, Gonzalez MC, Lu J, Jia G, Zheng J. Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia. Proc Nutr Soc. 2015, 74:355-66. 10.1017\/S0029665115000129","journal-title":"Proc Nutr Soc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.10.8855787","article-title":"Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study","volume":"81","author":"Brodsky IG","year":"1996","unstructured":"Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab. 1996, 81:3469-75. 10.1210\/jcem.81.10.8855787","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.92778","article-title":"Testosterone therapy in men in their 40s: a narrative review of indications, outcomes, and mid-term safety","volume":"17","author":"Canal de Velasco LM","year":"2025","unstructured":"Canal de Velasco LM, Gonz\u00e1lez Flores JE. Testosterone therapy in men in their 40s: a narrative review of indications, outcomes, and mid-term safety. Cureus. 2025, 17:e92778. 10.7759\/cureus.92778","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft AJ","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al.. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010, 39:412-23. 10.1093\/ageing\/afq034","journal-title":"Age Ageing"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.102894","article-title":"Psychiatric and cognitive effects of testosterone therapy in adult men: a systematic review of clinical evidence and mechanistic insights","volume":"18","author":"Canal de Velasco LM","year":"2026","unstructured":"Canal de Velasco LM, Gonz\u00e1lez Flores JE, Vargas L, Morales Arteaga JL. Psychiatric and cognitive effects of testosterone therapy in adult men: a systematic review of clinical evidence and mechanistic insights. Cureus. 2026, 18:e102894. 10.7759\/cureus.102894","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff AM","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P, et al.. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023, 389:107-17. 10.1056\/NEJMoa2215025","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2575","article-title":"Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis","volume":"95","author":"Fern\u00e1ndez-Balsells MM","year":"2010","unstructured":"Fern\u00e1ndez-Balsells MM, Murad MH, Lane M, et al.. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010, 95:2560-75. 10.1210\/jc.2009-2575","journal-title":"J Clin Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline","volume":"91","author":"Bhasin S","year":"2006","unstructured":"Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006, 91:1995-2010. 10.1210\/jc.2005-2847","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/0110-5558.72420","article-title":"Male hypogonadism: symptoms and treatment","volume":"1","author":"Kumar P","year":"2010","unstructured":"Kumar P, Kumar N, Thakur DS, Patidar A. Male hypogonadism: symptoms and treatment. J Adv Pharm Technol Res. 2010, 1:297-301. 10.4103\/0110-5558.72420","journal-title":"J Adv Pharm Technol Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-025-01128-0","article-title":"Variations in diagnostic criteria for male hypogonadism: is there a need for standardizing specialist society guidelines?","author":"Tsampoukas G","year":"2025","unstructured":"Tsampoukas G, Karna S, Morgado A, Minhas S. Variations in diagnostic criteria for male hypogonadism: is there a need for standardizing specialist society guidelines?. Int J Impot Res. 2025, 10.1038\/s41443-025-01128-0","journal-title":"Int J Impot Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234044","article-title":"Physical activity level and dietary intake associated with fat-free muscle mass changes during intentional weight loss in overweight and obese subjects","volume":"16","author":"Gariballa SE","year":"2024","unstructured":"Gariballa SE, Al-Bluwi G, Yasin J. Physical activity level and dietary intake associated with fat-free muscle mass changes during intentional weight loss in overweight and obese subjects. Nutrients. 2024, 16:10.3390\/nu16234044","journal-title":"Nutrients"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/474963-testosterone-replacement-therapy-as-a-potential-strategy-to-preserve-lean-mass-in-men-with-persistently-low-serum-testosterone-receiving-glp-1-receptor-agonists-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:39:03Z","timestamp":1774327143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/474963-testosterone-replacement-therapy-as-a-potential-strategy-to-preserve-lean-mass-in-men-with-persistently-low-serum-testosterone-receiving-glp-1-receptor-agonists-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.105734","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}